共 26 条
[1]
*CDCP, 2004, RESP SYNC VIR
[2]
Cost-effectiveness analysis of palivizumab in premature infants without chronic lung disease
[J].
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE,
2006, 160 (10)
:1070-1076
[3]
Elliott JP, 2003, J REPROD MED, V48, P713
[7]
Halsey NA, 1998, PEDIATRICS, V102, P1211, DOI 10.1542/peds.102.5.1211
[8]
Hospital admission of high risk infants for respiratory syncytial virus infection:: implications for palivizumab prophylaxis
[J].
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION,
2005, 90 (01)
:F64-F68